1. Home
  2. NTHI vs EVF Comparison

NTHI vs EVF Comparison

Compare NTHI & EVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTHI
  • EVF
  • Stock Information
  • Founded
  • NTHI 2008
  • EVF 1998
  • Country
  • NTHI United States
  • EVF United States
  • Employees
  • NTHI N/A
  • EVF N/A
  • Industry
  • NTHI Biotechnology: Pharmaceutical Preparations
  • EVF Investment Managers
  • Sector
  • NTHI Health Care
  • EVF Finance
  • Exchange
  • NTHI Nasdaq
  • EVF Nasdaq
  • Market Cap
  • NTHI 142.5M
  • EVF 102.2M
  • IPO Year
  • NTHI N/A
  • EVF N/A
  • Fundamental
  • Price
  • NTHI $7.24
  • EVF $5.64
  • Analyst Decision
  • NTHI
  • EVF
  • Analyst Count
  • NTHI 0
  • EVF 0
  • Target Price
  • NTHI N/A
  • EVF N/A
  • AVG Volume (30 Days)
  • NTHI 108.1K
  • EVF 93.3K
  • Earning Date
  • NTHI 01-01-0001
  • EVF 01-01-0001
  • Dividend Yield
  • NTHI N/A
  • EVF 10.68%
  • EPS Growth
  • NTHI N/A
  • EVF N/A
  • EPS
  • NTHI N/A
  • EVF 0.94
  • Revenue
  • NTHI $79,990.00
  • EVF N/A
  • Revenue This Year
  • NTHI N/A
  • EVF N/A
  • Revenue Next Year
  • NTHI N/A
  • EVF N/A
  • P/E Ratio
  • NTHI N/A
  • EVF $6.74
  • Revenue Growth
  • NTHI 13.52
  • EVF N/A
  • 52 Week Low
  • NTHI $4.11
  • EVF $5.20
  • 52 Week High
  • NTHI $25.00
  • EVF $6.84
  • Technical
  • Relative Strength Index (RSI)
  • NTHI N/A
  • EVF 48.82
  • Support Level
  • NTHI N/A
  • EVF $5.60
  • Resistance Level
  • NTHI N/A
  • EVF $5.69
  • Average True Range (ATR)
  • NTHI 0.00
  • EVF 0.05
  • MACD
  • NTHI 0.00
  • EVF -0.00
  • Stochastic Oscillator
  • NTHI 0.00
  • EVF 30.77

About NTHI NeOnc Technologies Holdings Inc. Common Stock

NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").

About EVF Eaton Vance Senior Income Trust

Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.

Share on Social Networks: